Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Shulman

Showing results (131-140 of 282) with videos related to

Pageof 29
Sort By:
The Oncologist|May 10, 2021
Moral Distress and Resilience Associated with Cancer Care Priority Setting in a Resource-Limited ContextRebecca J DeBoer, Espérance Mutoniwase, Cam Nguyen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2005
Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trialJennifer R Bellon, Steven E Come, Rebecca S Gelman, et al.
Bulletin of the World Health Organization|January 3, 2023
Breast cancer molecular diagnostics in Rwanda: a cost-minimization study of immunohistochemistry versus a novel GeneXpert<sup>®</sup> mRNA expression assayParsa Erfani, Esther Gaga, Emmanuel Hakizimana, et al.
JCO Global Oncology|May 18, 2022
Relative Dose Intensity and Pathologic Response Rates in Patients With Breast Cancer and With and Without HIV Who Received Neoadjuvant ChemotherapyYehoda M Martei, Mohan Narasimhamurthy, Dipho I Setlhako, et al.
Cancer|May 15, 1993
Cisplatin, 5-fluorouracil, and etoposide for advanced non-small cell lung cancerT J Lynch, F Kass, L A Kalish, et al.
AIDS (London, England)|June 21, 2001
Phenotypic hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in treatment-experienced HIV-infected patients: impact on virological response to efavirenz-based therapyN Shulman, A R Zolopa, D Passaro, et al.
The American Journal of Surgical Pathology|November 10, 2009
Partners in pathology: a collaborative model to bring pathology to resource poor settingsJoseph W Carlson, Evan Lyon, David Walton, et al.
JCO Global Oncology|November 5, 2020
Body Mass Index, Chemotherapy-Related Weight Changes, and Disease-Free Survival in Haitian Women With Nonmetastatic Breast CancerTemidayo Fadelu, Ruth Damuse, Joarly Lormil, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 1994
Phase I pharmacokinetic study of the hypoxic cell sensitizer etanidazole with carboplatin and cyclophosphamide in the treatment of advanced ovarian cancerL N Shulman, L Buswell, H Goodman, et al.
Journal of Surgical Oncology|November 1, 2018
Impact of delayed care on surgical management of patients with gastric cancer in a low-resource settingAllison N Martin, Allison Silverstein, Robinson Ssebuufu, et al.
Pageof 29

Showing results (131-140 of 282) with videos related to

Sort By:
Pageof 29
The Oncologist|May 10, 2021
Moral Distress and Resilience Associated with Cancer Care Priority Setting in a Resource-Limited ContextRebecca J DeBoer, Espérance Mutoniwase, Cam Nguyen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2005
Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trialJennifer R Bellon, Steven E Come, Rebecca S Gelman, et al.
Bulletin of the World Health Organization|January 3, 2023
Breast cancer molecular diagnostics in Rwanda: a cost-minimization study of immunohistochemistry versus a novel GeneXpert<sup>®</sup> mRNA expression assayParsa Erfani, Esther Gaga, Emmanuel Hakizimana, et al.
JCO Global Oncology|May 18, 2022
Relative Dose Intensity and Pathologic Response Rates in Patients With Breast Cancer and With and Without HIV Who Received Neoadjuvant ChemotherapyYehoda M Martei, Mohan Narasimhamurthy, Dipho I Setlhako, et al.
Cancer|May 15, 1993
Cisplatin, 5-fluorouracil, and etoposide for advanced non-small cell lung cancerT J Lynch, F Kass, L A Kalish, et al.
AIDS (London, England)|June 21, 2001
Phenotypic hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in treatment-experienced HIV-infected patients: impact on virological response to efavirenz-based therapyN Shulman, A R Zolopa, D Passaro, et al.
The American Journal of Surgical Pathology|November 10, 2009
Partners in pathology: a collaborative model to bring pathology to resource poor settingsJoseph W Carlson, Evan Lyon, David Walton, et al.
JCO Global Oncology|November 5, 2020
Body Mass Index, Chemotherapy-Related Weight Changes, and Disease-Free Survival in Haitian Women With Nonmetastatic Breast CancerTemidayo Fadelu, Ruth Damuse, Joarly Lormil, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 1994
Phase I pharmacokinetic study of the hypoxic cell sensitizer etanidazole with carboplatin and cyclophosphamide in the treatment of advanced ovarian cancerL N Shulman, L Buswell, H Goodman, et al.
Journal of Surgical Oncology|November 1, 2018
Impact of delayed care on surgical management of patients with gastric cancer in a low-resource settingAllison N Martin, Allison Silverstein, Robinson Ssebuufu, et al.
Pageof 29